nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—DRD4—conduct disorder	0.604	0.684	CbGaD
Iloperidone—HTR2A—conduct disorder	0.278	0.316	CbGaD
Iloperidone—HTR7—autonomic nervous system—conduct disorder	0.00277	0.273	CbGeAlD
Iloperidone—Paliperidone—DRD4—conduct disorder	0.00273	0.345	CrCbGaD
Iloperidone—Risperidone—DRD4—conduct disorder	0.00203	0.257	CrCbGaD
Iloperidone—HTR2A—autonomic nervous system—conduct disorder	0.00173	0.17	CbGeAlD
Iloperidone—Paliperidone—HTR2A—conduct disorder	0.00126	0.159	CrCbGaD
Iloperidone—Cisapride—HTR2A—conduct disorder	0.000953	0.121	CrCbGaD
Iloperidone—Risperidone—HTR2A—conduct disorder	0.000938	0.119	CrCbGaD
Iloperidone—DRD4—brain—conduct disorder	0.000851	0.0839	CbGeAlD
Iloperidone—DRD3—brain—conduct disorder	0.000598	0.059	CbGeAlD
Iloperidone—HTR6—brain—conduct disorder	0.000576	0.0568	CbGeAlD
Iloperidone—DRD1—brain—conduct disorder	0.000428	0.0422	CbGeAlD
Iloperidone—HTR1D—brain—conduct disorder	0.000336	0.0331	CbGeAlD
Iloperidone—HTR2C—brain—conduct disorder	0.000333	0.0328	CbGeAlD
Iloperidone—SIGMAR1—brain—conduct disorder	0.000313	0.0309	CbGeAlD
Iloperidone—HTR1A—brain—conduct disorder	0.00028	0.0276	CbGeAlD
Iloperidone—HTR7—brain—conduct disorder	0.000268	0.0264	CbGeAlD
Iloperidone—ADRA1A—brain—conduct disorder	0.000258	0.0255	CbGeAlD
Iloperidone—DRD2—brain—conduct disorder	0.000253	0.025	CbGeAlD
Iloperidone—ADRA2C—brain—conduct disorder	0.000246	0.0243	CbGeAlD
Iloperidone—HRH1—brain—conduct disorder	0.0002	0.0197	CbGeAlD
Iloperidone—ADRA2A—brain—conduct disorder	0.000196	0.0194	CbGeAlD
Iloperidone—CYP2E1—brain—conduct disorder	0.000192	0.0189	CbGeAlD
Iloperidone—HTR2A—brain—conduct disorder	0.000167	0.0165	CbGeAlD
Iloperidone—CYP2D6—brain—conduct disorder	0.000152	0.015	CbGeAlD
Iloperidone—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000124	0.00124	CbGpPWpGaD
Iloperidone—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000123	0.00123	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000123	0.00123	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000122	0.00122	CbGpPWpGaD
Iloperidone—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00122	CbGpPWpGaD
Iloperidone—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00122	CbGpPWpGaD
Iloperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000122	0.00122	CbGpPWpGaD
Iloperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000121	0.00122	CbGpPWpGaD
Iloperidone—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000121	0.00122	CbGpPWpGaD
Iloperidone—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000121	0.00121	CbGpPWpGaD
Iloperidone—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000121	0.00121	CbGpPWpGaD
Iloperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00012	0.0012	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000119	0.0012	CbGpPWpGaD
Iloperidone—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000118	0.00118	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000117	0.00118	CbGpPWpGaD
Iloperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000117	0.00117	CbGpPWpGaD
Iloperidone—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000115	0.00116	CbGpPWpGaD
Iloperidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000113	0.00113	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000112	0.00113	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000111	0.00111	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000109	0.00109	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00107	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00106	CbGpPWpGaD
Iloperidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00106	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00106	CbGpPWpGaD
Iloperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000105	0.00106	CbGpPWpGaD
Iloperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000105	0.00105	CbGpPWpGaD
Iloperidone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00105	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00105	CbGpPWpGaD
Iloperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000104	0.00104	CbGpPWpGaD
Iloperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000103	0.00104	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000103	0.00103	CbGpPWpGaD
Iloperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000102	0.00102	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000102	0.00102	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.66e-05	0.000969	CbGpPWpGaD
Iloperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	9.63e-05	0.000966	CbGpPWpGaD
Iloperidone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	9.63e-05	0.000966	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.61e-05	0.000964	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—CGA—conduct disorder	9.35e-05	0.000938	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.34e-05	0.000937	CbGpPWpGaD
Iloperidone—HTR6—GPCR ligand binding—HTR2A—conduct disorder	9.3e-05	0.000932	CbGpPWpGaD
Iloperidone—HTR7—GPCR ligand binding—HTR2A—conduct disorder	9.29e-05	0.000931	CbGpPWpGaD
Iloperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.26e-05	0.000929	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.26e-05	0.000929	CbGpPWpGaD
Iloperidone—CYP2D6—Biological oxidations—COMT—conduct disorder	9.23e-05	0.000926	CbGpPWpGaD
Iloperidone—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	9.22e-05	0.000925	CbGpPWpGaD
Iloperidone—HTR7—Circadian rythm related genes—EP300—conduct disorder	9.21e-05	0.000924	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.19e-05	0.000922	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—CGA—conduct disorder	9.17e-05	0.00092	CbGpPWpGaD
Iloperidone—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.16e-05	0.000919	CbGpPWpGaD
Iloperidone—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.11e-05	0.000914	CbGpPWpGaD
Iloperidone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.1e-05	0.000913	CbGpPWpGaD
Iloperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.09e-05	0.000912	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—DRD4—conduct disorder	9.09e-05	0.000912	CbGpPWpGaD
Iloperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.04e-05	0.000906	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	9e-05	0.000903	CbGpPWpGaD
Iloperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.99e-05	0.000902	CbGpPWpGaD
Iloperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.92e-05	0.000895	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.92e-05	0.000895	CbGpPWpGaD
Iloperidone—DRD4—GPCR ligand binding—HTR2A—conduct disorder	8.89e-05	0.000892	CbGpPWpGaD
Iloperidone—DRD4—Circadian rythm related genes—EP300—conduct disorder	8.81e-05	0.000884	CbGpPWpGaD
Iloperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.74e-05	0.000877	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—CGA—conduct disorder	8.48e-05	0.000851	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.36e-05	0.000839	CbGpPWpGaD
Iloperidone—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.36e-05	0.000838	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.35e-05	0.000838	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—CGA—conduct disorder	8.33e-05	0.000836	CbGpPWpGaD
Iloperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.29e-05	0.000832	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.29e-05	0.000831	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—CGA—conduct disorder	8.17e-05	0.00082	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—DRD4—conduct disorder	8.05e-05	0.000808	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—DRD4—conduct disorder	8.04e-05	0.000807	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—HTR2A—conduct disorder	8e-05	0.000803	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.99e-05	0.000801	CbGpPWpGaD
Iloperidone—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.93e-05	0.000796	CbGpPWpGaD
Iloperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.93e-05	0.000796	CbGpPWpGaD
Iloperidone—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.9e-05	0.000792	CbGpPWpGaD
Iloperidone—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.83e-05	0.000785	CbGpPWpGaD
Iloperidone—CYP1A2—Biological oxidations—COMT—conduct disorder	7.82e-05	0.000784	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.79e-05	0.000781	CbGpPWpGaD
Iloperidone—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.76e-05	0.000779	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CGA—conduct disorder	7.71e-05	0.000774	CbGpPWpGaD
Iloperidone—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.71e-05	0.000774	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CGA—conduct disorder	7.7e-05	0.000773	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CGA—conduct disorder	7.65e-05	0.000768	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.64e-05	0.000767	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.6e-05	0.000762	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CGA—conduct disorder	7.37e-05	0.00074	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—DRD4—conduct disorder	7.31e-05	0.000733	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—DRD4—conduct disorder	7.3e-05	0.000733	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—DRD4—conduct disorder	7.26e-05	0.000728	CbGpPWpGaD
Iloperidone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.22e-05	0.000724	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.1e-05	0.000712	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.93e-05	0.000695	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.88e-05	0.00069	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.85e-05	0.000687	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.84e-05	0.000686	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—CGA—conduct disorder	6.8e-05	0.000682	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.66e-05	0.000668	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.65e-05	0.000667	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CGA—conduct disorder	6.64e-05	0.000666	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—CGA—conduct disorder	6.61e-05	0.000663	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CGA—conduct disorder	6.55e-05	0.000657	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.29e-05	0.000631	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—DRD4—conduct disorder	6.21e-05	0.000623	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—WASF1—conduct disorder	6.18e-05	0.00062	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—WASF1—conduct disorder	6.17e-05	0.000619	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—WASF1—conduct disorder	6.13e-05	0.000615	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.04e-05	0.000606	CbGpPWpGaD
Iloperidone—CYP3A4—Biological oxidations—COMT—conduct disorder	6.03e-05	0.000605	CbGpPWpGaD
Iloperidone—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.99e-05	0.000601	CbGpPWpGaD
Iloperidone—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.99e-05	0.000601	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.96e-05	0.000598	CbGpPWpGaD
Iloperidone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.95e-05	0.000597	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.93e-05	0.000595	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.93e-05	0.000595	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—WASF1—conduct disorder	5.91e-05	0.000593	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.82e-05	0.000584	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.77e-05	0.000578	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CGA—conduct disorder	5.71e-05	0.000573	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CGA—conduct disorder	5.68e-05	0.00057	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.52e-05	0.000554	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.41e-05	0.000543	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.41e-05	0.000543	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.38e-05	0.00054	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CGA—conduct disorder	5.37e-05	0.000538	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—WASF1—conduct disorder	5.32e-05	0.000534	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	5.25e-05	0.000527	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—WASF1—conduct disorder	5.25e-05	0.000527	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	5.25e-05	0.000526	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.24e-05	0.000525	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.23e-05	0.000525	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	5.21e-05	0.000523	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.15e-05	0.000516	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.14e-05	0.000515	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.04e-05	0.000506	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	5.02e-05	0.000504	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CGA—conduct disorder	5.01e-05	0.000503	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CGA—conduct disorder	4.93e-05	0.000495	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CGA—conduct disorder	4.93e-05	0.000494	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CGA—conduct disorder	4.92e-05	0.000494	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CGA—conduct disorder	4.92e-05	0.000493	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.83e-05	0.000484	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.77e-05	0.000479	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.77e-05	0.000478	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.75e-05	0.000477	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.73e-05	0.000475	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.68e-05	0.00047	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.68e-05	0.000469	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.67e-05	0.000468	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.58e-05	0.000459	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.58e-05	0.000459	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.56e-05	0.000458	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.55e-05	0.000457	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.52e-05	0.000454	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.49e-05	0.00045	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.46e-05	0.000448	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.43e-05	0.000444	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—DRD4—conduct disorder	4.32e-05	0.000433	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—DRD4—conduct disorder	4.31e-05	0.000433	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.29e-05	0.00043	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.25e-05	0.000427	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.11e-05	0.000412	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	4.05e-05	0.000406	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—WASF1—conduct disorder	4.02e-05	0.000403	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.95e-05	0.000397	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—WASF1—conduct disorder	3.94e-05	0.000396	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.89e-05	0.00039	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.87e-05	0.000388	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.87e-05	0.000388	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.76e-05	0.000377	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—DRD4—conduct disorder	3.72e-05	0.000373	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—DRD4—conduct disorder	3.67e-05	0.000368	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.6e-05	0.000361	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.53e-05	0.000354	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.51e-05	0.000352	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CGA—conduct disorder	3.5e-05	0.000351	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.42e-05	0.000343	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.41e-05	0.000342	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.35e-05	0.000336	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.29e-05	0.00033	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.2e-05	0.000321	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.18e-05	0.000319	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—EP300—conduct disorder	3.15e-05	0.000316	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.1e-05	0.000311	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.09e-05	0.00031	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—COMT—conduct disorder	3.07e-05	0.000308	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.06e-05	0.000307	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—MAOA—conduct disorder	3.05e-05	0.000306	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.04e-05	0.000305	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.99e-05	0.0003	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—COMT—conduct disorder	2.98e-05	0.000299	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CGA—conduct disorder	2.96e-05	0.000297	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—MAOA—conduct disorder	2.96e-05	0.000297	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.82e-05	0.000283	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.81e-05	0.000282	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—DRD4—conduct disorder	2.81e-05	0.000282	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.8e-05	0.000281	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.78e-05	0.000278	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.76e-05	0.000277	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—DRD4—conduct disorder	2.76e-05	0.000276	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.7e-05	0.000271	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.69e-05	0.00027	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—EP300—conduct disorder	2.56e-05	0.000257	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.51e-05	0.000252	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.43e-05	0.000243	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—COMT—conduct disorder	2.42e-05	0.000243	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—MAOA—conduct disorder	2.41e-05	0.000241	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.39e-05	0.00024	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CGA—conduct disorder	2.29e-05	0.000229	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—COMT—conduct disorder	2.22e-05	0.000223	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—COMT—conduct disorder	2.22e-05	0.000223	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—MAOA—conduct disorder	2.21e-05	0.000222	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—MAOA—conduct disorder	2.2e-05	0.000221	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.09e-05	0.000209	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.08e-05	0.000208	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	2.02e-05	0.000202	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.83e-05	0.000184	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.8e-05	0.00018	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.76e-05	0.000177	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.64e-05	0.000164	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—COMT—conduct disorder	1.58e-05	0.000158	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MAOA—conduct disorder	1.57e-05	0.000157	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EP300—conduct disorder	1.48e-05	0.000149	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EP300—conduct disorder	1.43e-05	0.000143	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—COMT—conduct disorder	1.34e-05	0.000134	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MAOA—conduct disorder	1.33e-05	0.000133	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—EP300—conduct disorder	1.32e-05	0.000132	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.29e-05	0.000129	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000129	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—EP300—conduct disorder	1.28e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EP300—conduct disorder	1.27e-05	0.000127	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EP300—conduct disorder	1.11e-05	0.000111	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.00011	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.07e-05	0.000107	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—EP300—conduct disorder	1.04e-05	0.000104	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—COMT—conduct disorder	1.03e-05	0.000104	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MAOA—conduct disorder	1.02e-05	0.000103	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EP300—conduct disorder	9.7e-06	9.73e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EP300—conduct disorder	9.55e-06	9.58e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—EP300—conduct disorder	9.54e-06	9.57e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EP300—conduct disorder	9.53e-06	9.56e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—EP300—conduct disorder	9.52e-06	9.55e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.35e-06	9.38e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.69e-06	8.71e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—EP300—conduct disorder	6.77e-06	6.79e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—EP300—conduct disorder	5.73e-06	5.75e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—EP300—conduct disorder	4.43e-06	4.44e-05	CbGpPWpGaD
